Research Analysts Set Expectations for ASND FY2026 Earnings
Ascendis Pharma A/S (NASDAQ:ASND – Free Report) – Equities researchers at Cantor Fitzgerald issued their FY2026 earnings per share estimates for shares of Ascendis Pharma A/S in a research note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst L. Watsek anticipates that the biotechnology company will post earnings per share of $3.43 for […]
Ascendis Pharma A/S (NASDAQ:ASND – Free Report) – Equities researchers at Cantor Fitzgerald issued their FY2026 earnings per share estimates for shares of Ascendis Pharma A/S in a research note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst L. Watsek anticipates that the biotechnology company will post earnings per share of $3.43 for […]
